Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderReal

CONCLUSION: The pathfinderReal study will provide insights regarding the impact of N8-GP on joint health in persons with hemophilia A in a real-world setting.PMID:38572481 | PMC:PMC10987329 | DOI:10.1016/j.rpth.2024.102363
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Source Type: research